2Aronow WS, Ahn C, Kronzon I. Effect of propranolol versus nopropranolol on total mortality plus nonfatal myocardial infarction in older patient with prior myocardial infarction, congestive heart failure and left ventricular ejection fraction>40% treated with diuretics plus angiotensin-converting enzymeinhibitors inhibitors[J].AM J Cardiol, 1997,(80):207-209.
3The Digitalis Investigation Group.The effect of digoxin on mortality and morbidity in patients with heart failure[J].N Engl J Med,1997,336:525-533.
4Min Zi, Neil Camichael, Michael Lye. The effect of quinapril on functional status of elderly patients with diastolic heart failure[J].Cardiovasc. Drug. Ther, 2003,3(17):133.
5Yusuf S,Pfeffer MA, Swedbery K,et al. Candesartan in heart failure assessment of reduction in mortality and morbidity[J].Lancet,2003,362:777-781.
6Dahlf B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol[J]. Lancet,2002,359:995-1003.
7Yoshida J, Yamamoto K, Mano T, et al. AT1 receptor blocker added to ACE inhibitor provides benefits at advanced stage of hypertensive diastolic heart failure[J].Hypertension,2004,43(3): 686-691.
8Pittd, Zannad F, Remme WJ, et al. The effect of Spironolacton on morbidity and mortlity in patients with severe heart failure[J]. New Engl J Med,1999,341:709-717.
9Szatkowski ML,Westfall MV, Gomez CA,et al.In vivo acceleration of heart relaxation performance of parvalbumin gene delivery[J].J Clin Invest,2001,107(2):191-198.
10Aronow, WS. left ventricular diastolic heart failure with normal left ventricular systolic function in older persons[J].J Lab Clin Med,2001,137(5): 316-323.
